Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002–2023)
Clinical Infectious Diseases · 17.03.2026 · 82 (3) · e511-e520
DOI: 10.1093/cid/ciaf407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 24.07.2025. Verfasst von Juan Berenguer und 43 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Hauptthemen laut MEDLINE: HIV Infections, Hepatitis C, Coinfection. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación para la Investigación y la Prevención del Sida en España, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Background
Hepatitis C virus (HCV) has significantly impacted people with human immunodeficiency virus (HIV). Harm reduction programs, changing transmission patterns, and direct-acting antivirals (DAAs) have profoundly altered HIV/HCV coinfection trends. This study evaluates HCV prevalence among people with HIV in Spain over 2 decades.
Methods
We conducted 9 cross-sectional studies (2002–2023) in 39–43 centers. Sampled individuals were randomly sampled from people with HIV actively followed up at these centers, with proportional allocation. Main outcomes included the prevalence of anti-HCV antibody and active HCV infection (HCV RNA–positive result).
Results
The reference population ranged from 31 800 to 47 006, with sample sizes of 1260–1867. HIV transmission patterns shifted from 2002 to 2023, with injection drug use decreasing from 55% to 21% and the proportion of men who have sex with men increasing from 17% to 46%. HCV seroprevalence fell from 60.8% to 27.4%, and active infection from 46.3% to 0.9%. In the DAA era (2015–2023), active HCV infection dropped by 100% in heterosexuals, 94% in people who inject drugs, and 71% in men who have sex with men. Treatment uptake increased from 23% in 2002 to 99% by 2023 with all-oral DAAs. The prevalence of cirrhosis among active HCV cases peaked at 23.1% in 2015 but fell to 0% by 2021. Among those achieving sustained virologic response, cirrhosis prevalence was 20.4% in 2023.
Conclusions
HIV/HCV coinfection has drastically declined in Spain, with active HCV infection prevalence <1% since 2021. DAAs were pivotal in this achievement. However, cirrhosis remains a concern among those with sustained virologic response. Ongoing surveillance and prevention efforts are essential to sustain these gains and address residual risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
- Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
- Infectious Diseases, Hospital Universitario La Paz, Madrid, Spain.
- Instituto de Investigación Sanitaria Hospital La Paz (IdiPAZ), Madrid, Spain.
- Infectious Diseases, Hospital Universitario Ramón y Cajal, Madrid, Spain.
ORCID-Profile: Juan Berenguer, Chiara Fanciulli, María J Vivancos, Pere Domingo, Asunción Hernando, Pablo Ryan, Luis E Morano, José A Iribarren, Rosa Martínez, María J Galindo, Ignacio de Los Santos, Ian López-Cruz, Antonio Rivero, Livia Giner, Marta Montero-Alonso, Juan E Losa, Enrique Bernal, Cristina Martín, Ramón Teira, Juan González-García
Förderung
- Fundación para la Investigación y la Prevención del Sida en España
- Instituto de Salud Carlos III
Zitieren
APA
Berenguer, J., Fanciulli, C., Arcos, M. M., Vivancos, M. J., Domingo, P., Hernando, A., Barrado, J., Ryan, P., Navarro, J., Palacios, R., Morano, L. E., Iribarren, J. A., Martínez, R., Galindo, M. J., de Los Santos, I., López-Cruz, I., Rivero, A., Pérez-Latorre, L., Giner, L., …, & González-García, J. (2026). Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002–2023). Clinical Infectious Diseases, 82(3), e511-e520. https://doi.org/10.1093/cid/ciaf407
Vancouver
Berenguer J, Fanciulli C, Arcos MM, Vivancos MJ, Domingo P, Hernando A, et al. Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002–2023). Clinical Infectious Diseases. 2026;82(3):e511-e520. doi:10.1093/cid/ciaf407
BibTeX
@article{Berenguer2026,
author = {Berenguer, Juan and Fanciulli, Chiara and Arcos, María M and Vivancos, María J and Domingo, Pere and Hernando, Asunción and Barrado, Julia and Ryan, Pablo and Navarro, Jordi and Palacios, Rosario and Morano, Luis E and Iribarren, José A and Martínez, Rosa and Galindo, María J and de Los Santos, Ignacio and López-Cruz, Ian and Rivero, Antonio and Pérez-Latorre, Leire and Giner, Livia and Fariñas, María C and García, Coral and Montero-Alonso, Marta and Ferrero, Óscar L and Villoslada, Aroa and Soler-González, Josefa F and Sanz, José and Rodríguez, Sergio and Losa, Juan E and Bernal, Enrique and Veloso, Sergio and Pérez-Martínez, Laura and Mateos, Fernando and Arbonés, Laia and Franch, Raquel and Corps, Diana and Martín, Cristina and Alonso, Gerardo and Clavero-Olmos, Marta and Silvariño, Rafael and Teira, Ramón and Belinchón, Olga and de Miguel, Marta and Jarrín, Inmaculada and González-García, Juan},
title = {Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002–2023)},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {82},
number = {3},
pages = {e511--e520},
doi = {10.1093/cid/ciaf407}
}
EUVIMED